Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 2—February 2022
Research

Effectiveness of mRNA BNT162b2 Vaccine 6 Months after Vaccination among Patients in Large Health Maintenance Organization, Israel

Jennifer KertesComments to Author , Sharon Baruch Gez, Yaki Saciuk, Lia Supino-Rosin, Naama Shamir Stein, Miri Mizrahi-Reuveni, and Anat E. Zohar
Author affiliation: Maccabi HealthCare Services, Tel Aviv‒Jaffa Israel

Main Article

Table 5

Factors associated with coronavirus disease for population vaccinated against coronavirus disease, by logistic regression model, Maccabi Healthcare Services, Israel, January‒July 2021

Variable No. Adjusted odds ratio (95% CI)
Vaccination period
Jan‒Feb 821,231 1.61 (1.45–1.79)
Mar‒May 601,867 Referent
Sex
M 681,382 0.11 (1.01–1.20)
F 741,716 Referent
Age group, y
<18 84,025 Referent
18–44 625,865 1.92 (1.51–2.49)
45–59 375,826 1.88 (1.46–2.45)
60–74 248,057 1.54 (1.17–2.04)
.>75 89,325 1.06 (0.75–1.50)
Socioeconomic status
Low 228,613 Referent
Moderate 706,198 2.85 (2.34–3.50)
High 488,287 4.40 (3.61–5.41)
Heart disease
No 1,348,587 Referent
Yes 74,511 1.35 (1.11–1.79)
Diabetes
No 1,299,843 Referent
Yes 123,255 1.03 (0.87–1.12)
Hypertension
No 1,149,913 Referent
Yes 273,185 0.98 (0.86–1.22)
Chronic kidney disease
No 1,355,164 Referent
Yes 67,934 0.82 (0.63–1.05)
Immunosuppressive disorder
No 1,406,596 Referent
Yes 16,502 0.90 (0.58–1.63)

Main Article

Page created: November 16, 2021
Page updated: January 22, 2022
Page reviewed: January 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external